Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever. - Wikidata - wikimedia - TriplyDB

Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever.

Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever.

http://www.wikidata.org/entity/Q33619248

about

Q fever Q fever in Bulgaria and Slovakia.Changing epidemiology of Q fever in Germany, 1947-1999.Vaccination against Q fever for biodefense and public health indications.Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice.Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis.Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii MPLEx: a method for simultaneous pathogen inactivation and extraction of samples for multi-omics profiling.

P2860

Q24550722-9B944F3D-EEF6-4FC8-8E6C-BDCBCB2419C5 Q33643102-B0FCF538-A2FA-4834-87B1-668D82D412DA Q34465374-001D121C-DCB8-42D2-AD83-7F9DFE79273E Q34708529-38709F03-32FD-4492-A7F4-FA10895AB16E Q35613616-F87FCD93-3DAD-4CB6-8563-DCB4C657F151 Q35615074-4AC1949C-203E-4790-8AB8-6E58775914EF Q36933033-0A4C9DAA-02D7-48F7-87A5-50EF55762BAE Q38721171-92BE4BDD-D0D7-40EA-891B-F6CC6107B3C0

P2860

Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever.

http://www.wikidata.org/entity/Q33619248

description

1993 nî lūn-bûn

@nan

1993 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1993 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

name

Safety and immunogenicity in h ...... l residue vaccine for Q fever.

@ast

Safety and immunogenicity in h ...... l residue vaccine for Q fever.

@en

type

label

Safety and immunogenicity in h ...... l residue vaccine for Q fever.

@ast

Safety and immunogenicity in h ...... l residue vaccine for Q fever.

@en

prefLabel

Safety and immunogenicity in h ...... l residue vaccine for Q fever.

@ast

Safety and immunogenicity in h ...... l residue vaccine for Q fever.

@en

P1433

Q33619248-AB59B1D8-36EF-4DB9-9FED-B3B8CE8433B0

P1476

Q33619248-DF055EAE-D8D6-491D-B163-76BBC78A8008

P2093

Q33619248-00B22A3F-E0D9-4945-9F57-5C19AC03E22D

Q33619248-4EA9ED0B-28B9-46C1-892D-CDA6AC222057

Q33619248-8DEBE410-18BA-403C-8BF8-316F56E9F981

P2860

Q33619248-0966234D-6961-42F2-B497-7602DF62D132

Q33619248-0DCCEC68-4D7D-436C-B4C2-A396FF2225F5

Q33619248-21FE2360-A7EA-43AA-877C-6327BB8E2AD1

Q33619248-33ED1B36-D907-47C8-8DAA-AFBAFC56B0D1

Q33619248-393D2D96-0DB5-46CB-9304-623A6789CF8E

Q33619248-3AA35653-C94D-4656-9539-34B3544D219E

Q33619248-3D947EC5-5520-4EA0-A9F9-C5196F5FA36A

Q33619248-457954E3-4CE9-454B-B591-A76AD8A493B9

Q33619248-573F4101-1485-4166-BA06-7250E539C3E7

Q33619248-5F2F2652-A0C4-4CC0-B238-048C3E009FC3

P304

Q33619248-A237B96A-E723-4580-98F7-9F4B6710461B

P31

Q33619248-39C5F068-96B8-4998-BA09-980692FAB849

P407

Q33619248-E14A4358-E1DF-4B0E-BE06-AB68544A426A

P433

Q33619248-EE60304A-49EB-405D-B76C-B40E71BF1A18

P478

Q33619248-6D788F0F-6927-4734-99AF-2FE9208FCF46

P577

Q33619248-7A46077D-4EED-4295-9E65-660BE27BFCC2

P698

Q33619248-EEB472A4-D47F-48D6-BFAF-3D3DB006FE95

P932

Q33619248-3B28AE80-B637-4882-84E4-20E1D8F03025

P1433

Infection and Immunity

P1476

Safety and immunogenicity in h ...... l residue vaccine for Q fever.

@en

P2093

Fries LF

http://www.w3.org/2001/XMLSchema#string

Waag DM

http://www.w3.org/2001/XMLSchema#string

Williams JC

http://www.w3.org/2001/XMLSchema#string

P2860

Correlation between the expression of an Escherichia coli cell surface protein and the ability of the protein to bind to lipopolysaccharide

Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine

Chemical and immunological characterization of lipopolysaccharides from phase I and phase II Coxiella burnetii.

Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.

Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations.

Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice.

Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs.

Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice.

Monoclonal antibodies distinguish phase variants of Coxiella burnetii.

Dermal granulomatous hypersensitivity in Q fever: comparative studies of the granulomatous potential of whole cells of Coxiella burnetii phase I and subfractions

P304

1251-1258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

1993-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8454328

http://www.w3.org/2001/XMLSchema#string

P932

281355

http://www.w3.org/2001/XMLSchema#string